Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications

MA Fouad, H Abdel-Hamid, MS Ayoup - RSC advances, 2020 - pubs.rsc.org
Multicomponent reactions (MCRs) are powerful synthetic tools in which more than two
starting materials couple with each other to form multi-functionalized compounds in a one …

Drugging undruggable molecular cancer targets

JS Lazo, ER Sharlow - Annual review of pharmacology and …, 2016 - annualreviews.org
Cancer, more than any other human disease, now has a surfeit of potential molecular targets
poised for therapeutic exploitation. Currently, a number of attractive and validated cancer …

A score years' update in the synthesis and biological evaluation of medicinally important 2-pyridones

S Sangwan, N Yadav, R Kumar, S Chauhan… - European Journal of …, 2022 - Elsevier
Pyridone core structure has attracted much attention due to its abundance in natural
products of biological importance. 2-Pyridone derivatives display diverse biological …

Photoredox-catalyzed coupling of acyl oxime acetates with thiophenols to give arylthioesters in water at room temperature

Y Fu, S Zhu, X Zhao, S Huang - Green Chemistry, 2022 - pubs.rsc.org
Photoredox catalysis in water has been receiving increasing attention due to its merits of
being environment friendly, inexpensive, and safe. However, efficient approaches to …

Design, synthesis, anticancer evaluation and molecular docking studies of 1, 2, 4-oxadiazole incorporated indazole-isoxazole derivatives

J Lingam, BK Sahoo, BD Mallavarapu… - Synthetic …, 2024 - Taylor & Francis
Abstract A new series of 1, 2, 4-oxadiazole incorporated indazole-isoxazole (12a–j)
derivatives were designed, synthesized and confirmed their structures by 1HNMR, 13CNMR …

Ru (ii)-Catalyzed C6-selective C–H amidation of 2-pyridones

L Zhang, X Zheng, J Chen, K Cheng, L Jin… - Organic Chemistry …, 2018 - pubs.rsc.org
Ru (II)-Catalyzed C6 site-selective amidation of 2-pyridones with 1, 4, 2-dioxazol-5-ones has
been developed. The reaction occurred with a low catalyst loading and broad substrate …

Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor

KE McQueeney, JM Salamoun, JC Burnett… - …, 2017 - pmc.ncbi.nlm.nih.gov
Overexpression of protein tyrosine phosphatase PTP4A oncoproteins is common in many
human cancers and is associated with poor patient prognosis and survival. We observed …

Photooxygenation of an amino-thienopyridone yields a more potent PTP4A3 inhibitor

JM Salamoun, KE McQueeney, K Patil… - Organic & …, 2016 - pubs.rsc.org
The phosphatase PTP4A3 is an attractive anticancer target, but knowledge of its exact role
in cells remains incomplete. A potent, structurally novel inhibitor of the PTP4A family was …

Development of an automated screen for Kv7. 2 potassium channels and discovery of a new agonist chemotype

CC Hernandez, RA Tarfa, JMI Limcaoco, R Liu… - Bioorganic & medicinal …, 2022 - Elsevier
To identify pore domain ligands on Kv7. 2 potassium ion channels, we compared wild-type
(WT) and W236L mutant Kv7. 2 channels in a series of assays with previously validated and …

Small molecule targeting of PTPs in cancer

JS Lazo, KE McQueeney, JC Burnett, P Wipf… - The international journal …, 2018 - Elsevier
Protein tyrosine phosphatases (PTPs) undeniably have a central role in the development
and progression of human cancers. Historically, however, PTPs have not been viewed as …